226 related articles for article (PubMed ID: 31797520)
1. Lymphovascular invasion and presence of embryonal carcinoma as risk factors for occult metastatic disease in clinical stage I nonseminomatous germ cell tumour: a systematic review and meta-analysis.
Blok JM; Pluim I; Daugaard G; Wagner T; Jóźwiak K; Wilthagen EA; Looijenga LHJ; Meijer RP; Bosch JLHR; Horenblas S
BJU Int; 2020 Mar; 125(3):355-368. PubMed ID: 31797520
[TBL] [Abstract][Full Text] [Related]
2. Microvascular invasion of testicular nonseminomatous germ cell tumors: implications of separate evaluation of lymphatic and blood vessels.
Heinzelbecker J; Gross-Weege M; Weiss C; Hörner C; Trunk MJ; Erben P; Haecker A; Bolenz C
J Urol; 2014 Aug; 192(2):593-9. PubMed ID: 24631105
[TBL] [Abstract][Full Text] [Related]
3. A refined risk stratification scheme for clinical stage 1 NSGCT based on evaluation of both embryonal predominance and lymphovascular invasion.
Lago-Hernandez CA; Feldman H; O'Donnell E; Mahal BA; Perez V; Howard S; Rosenthal M; Cheng SC; Nguyen PL; Beard C; D'Amico AV; Sweeney CJ
Ann Oncol; 2015 Jul; 26(7):1396-401. PubMed ID: 25888612
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in patients with clinical stage I nonseminoma-beyond lymphovascular invasion: a systematic review.
Zengerling F; Beyersdorff D; Busch J; Heinzelbecker J; Pfister D; Ruf C; Winter C; Albers P; Kliesch S; Schmidt S
World J Urol; 2022 Dec; 40(12):2879-2887. PubMed ID: 35906286
[TBL] [Abstract][Full Text] [Related]
5. Risk stratification of pubertal children and postpubertal adolescents with clinical stage I testicular nonseminomatous germ cell tumors.
Cost NG; Lubahn JD; Adibi M; Romman A; Wickiser JE; Raj GV; Sagalowsky AI; Margulis V
J Urol; 2014 May; 191(5 Suppl):1485-90. PubMed ID: 24679874
[TBL] [Abstract][Full Text] [Related]
6. alpha-Catenin expression pattern and DNA image-analysis cytometry have no additional value over primary histology in clinical stage I nonseminomatous testicular cancer.
Spermon JR; De Wilde PC; Hanselaar AG; Schaafsma HE; Ruijter TE; Witjes JA; Van Moorselaar RJ
BJU Int; 2002 Feb; 89(3):278-84. PubMed ID: 11856111
[TBL] [Abstract][Full Text] [Related]
7. Do Nonseminomatous Germ Cell Tumors of the Testis With Lymphovascular Invasion of the Spermatic Cord Merit Staging as pT3?
Gordetsky J; Sanfrancesco J; Epstein JI; Trevino K; Xu H; Osunkoya A; Xiao GQ; Kao CS; Unger P; Hashemi-Sadraei N; Albany C; Jorns JM; Lu DY; Matoso A; Rais-Bahrami S; Schwartz LE; Ulbright TM; Idrees MT
Am J Surg Pathol; 2017 Oct; 41(10):1397-1402. PubMed ID: 28719463
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of surveillance versus adjuvant chemotherapy for patients with stage IA and IB nonseminomatous testicular germ cell tumors.
Gumus M; Bilici A; Odabas H; Ustaalioglu BBO; Kandemir N; Demirci U; Cihan S; Bayoglu IV; Ozturk T; Turkmen E; Urakci Z; Seker MM; Gunaydin Y; Selcukbiricik F; Turan N; Sevinc A
World J Urol; 2017 Jul; 35(7):1103-1110. PubMed ID: 27812752
[TBL] [Abstract][Full Text] [Related]
9. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis.
Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW
Cancer; 1998 Sep; 83(5):1002-11. PubMed ID: 9731905
[TBL] [Abstract][Full Text] [Related]
10. Re: Lymphovascular Invasion and Presence of Embryonal Carcinoma as Risk Factors for Occult Metastatic Disease in Clinical Stage I Nonseminomatous Germ Cell Tumour: A Systematic Review and Meta-Analysis.
Richie JP
J Urol; 2020 Oct; 204(4):881. PubMed ID: 32716238
[No Abstract] [Full Text] [Related]
11. Immunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.
Albers P; Miller GA; Orazi A; Ulbright TM; Albers J; Donohue JP; Foster RS
Cancer; 1995 Feb; 75(3):844-50. PubMed ID: 7828136
[TBL] [Abstract][Full Text] [Related]
12. Does the histology of nodal metastasis predict systemic relapse after retroperitoneal lymph node dissection in pathological stage B1 germ cell tumors?
Beck SD; Foster RS; Bihrle R; Cheng L; Donohue JP
J Urol; 2005 Oct; 174(4 Pt 1):1287-90; discussion 1290. PubMed ID: 16145394
[TBL] [Abstract][Full Text] [Related]
13. [Histopathologic and biological prognostic factors of clinical stage I non-seminomatous germ cell tumors. Implications for risk-adjusted therapy].
Heidenreich A; Sesterhenn IA; Mostofi FK; Moul JW; Engelmann UH
Urologe A; 1999 Mar; 38(2):168-78. PubMed ID: 10231939
[TBL] [Abstract][Full Text] [Related]
14. The role of lymph vessel density and lymphangiogenesis in metastatic tumor spread of nonseminomatous testicular germ cell tumors.
Heinzelbecker J; Gropp T; Weiss C; Huettl K; Stroebel P; Haecker A; Bolenz C; Trojan L
Urol Oncol; 2014 Feb; 32(2):178-85. PubMed ID: 23141777
[TBL] [Abstract][Full Text] [Related]
15. The Significance of Lymphovascular Invasion of the Spermatic Cord in the Absence of Cord Soft Tissue Invasion.
McCleskey BC; Epstein JI; Albany C; Hashemi-Sadraei N; Idrees MT; Jorns JM; Lu DY; Matoso A; Rais-Bahrami S; Schwartz LE; Ulbright TM; Gordetsky J
Arch Pathol Lab Med; 2017 Jun; 141(6):824-829. PubMed ID: 28362157
[TBL] [Abstract][Full Text] [Related]
16. Surgical management of low-stage nonseminomatous germ cell testicular cancer.
Stephenson AJ; Klein EA
BJU Int; 2009 Nov; 104(9 Pt B):1362-8. PubMed ID: 19840014
[TBL] [Abstract][Full Text] [Related]
17. Lymphovascular invasion as a poor prognostic indicator in thoracic esophageal carcinoma: a systematic review and meta-analysis.
Wang A; Tan Y; Geng X; Chen X; Wang S
Dis Esophagus; 2019 Feb; 32(2):. PubMed ID: 30169614
[TBL] [Abstract][Full Text] [Related]
18. Do Histopathologic Variables Affect the Reporting of Lymphovascular Invasion in Testicular Germ Cell Tumors?
French BL; Zynger DL
Am J Clin Pathol; 2016 Mar; 145(3):341-9. PubMed ID: 27124916
[TBL] [Abstract][Full Text] [Related]
19. Concordance and prediction ability of original and reviewed vascular invasion and other prognostic parameters of clinical stage I nonseminomatous germ cell testicular tumors after retroperitoneal lymph node dissection.
Nicolai N; Colecchia M; Biasoni D; Catanzaro M; Stagni S; Torelli T; Necchi A; Piva L; Milani A; Salvioni R
J Urol; 2011 Oct; 186(4):1298-302. PubMed ID: 21849196
[TBL] [Abstract][Full Text] [Related]
20. Pathological predictors of metastatic disease in testicular non-seminomatous germ cell tumors: which tumor-node-metastasis staging system?
Scandura G; Wagner T; Beltran L; Alifrangis C; Shamash J; Berney DM
Mod Pathol; 2021 Apr; 34(4):834-841. PubMed ID: 33319858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
